Zygote Intrafallopian Transfer (ZIFT) is a reproductive procedure commonly used in infertility treatments. It involves the intervention of medical professionals to assist couples in achieving pregnancy. ZIFT combines elements of in vitro fertilization (IVF) and intrafallopian transfer (IFT) to increase the chances of successful fertilization and implantation.
During ZIFT, eggs are collected from the woman's ovaries through transvaginal ultrasound-guided follicular aspiration. Meanwhile, sperm is retrieved from the male partner or a sperm donor through ejaculation or testicular aspiration. In the laboratory setting, the eggs and sperm are placed together to allow for fertilization to occur. This fertilized egg, known as a zygote, is then inserted into the woman's fallopian tube. This procedure is typically performed 24 hours after egg retrieval.
The transfer of the zygote into the fallopian tube allows for its natural progression towards implantation in the uterus. Within days, the zygote begins dividing, forming an embryo that travels down the tube to the uterus for implantation and eventual pregnancy.
ZIFT differs from traditional IVF in that the transfer occurs in the fallopian tube rather than the uterus. This method may be preferred for couples with specific fertility issues, such as tubal blockages or infertility due to sperm dysfunction. By bypassing potential barriers in the fallopian tubes, ZIFT can increase the chances of a successful pregnancy.
In summary, Zygote Intrafallopian Transfer is a fertility treatment combining aspects of IVF and IFT. It involves the collection and fertilization of eggs in the laboratory, followed by the placement of the zygote into the woman's fallopian tube. This technique aims to improve the chances of
